Historical Stock Price
BHVN historical stock prices picture
Biohaven (BHVN) has the following price history information. Looking back at BHVN historical stock prices for the last five trading days, on April 22, 2024, BHVN opened at $39.70, traded as high as $39.70 and as low as $38.19, and closed at $38.33. Trading volume was a total of 1.13M shares. On April 23, 2024, BHVN opened at $40.54, traded as high as $41.88 and as low as $39.25, and closed at $39.61. Trading volume was a total of 2.09M shares. On April 24, 2024, BHVN opened at $40.19, traded as high as $40.62 and as low as $38.38, and closed at $38.72. Trading volume was a total of 971.90K shares. On April 25, 2024, BHVN opened at $38.95, traded as high as $38.95 and as low as $36.77, and closed at $38.54. Trading volume was a total of 1.85M shares. On April 26, 2024, BHVN opened at $38.61, traded as high as $39.28 and as low as $37.75, and closed at $38.97. Trading volume was a total of 947.30K shares.

BHVN Historical Stock Prices By Date:

BHVN historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Biohaven shares, starting with a $10,000 purchase of BHVN, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 05/05/2017
End date: 04/26/2024
Start price/share: $17.91
End price/share: $38.97
Dividends collected/share: $0.00
Total return: 117.59%
Average Annual Total Return: 11.78%
Starting investment: $10,000.00
Ending investment: $21,758.11
Years: 6.98
Date Open High Low Close Volume
04/22/2024 $39.70 $39.70 $38.19 $38.33 1.13M
04/23/2024 $40.54 $41.88 $39.25 $39.61 2.09M
04/24/2024 $40.19 $40.62 $38.38 $38.72 971.90K
04/25/2024 $38.95 $38.95 $36.77 $38.54 1.85M
04/26/2024 $38.61 $39.28 $37.75 $38.97 947.30K
Biohaven is a clinical-stage biopharmaceutical company focused on therapies for patients with neurological and neuropsychiatric diseases. Co. has obtained drug approvals for products for diseases such as migraine, depression, bipolar and schizophrenia, and its research programs, develop therapies with indications in epilepsy, mood disorders, Obsessive-Compulsive Disorder, Spinocerebellar Ataxia, Spinal Muscular Atrophy and pain disorders. Co.'s neuroscience portfolio includes a range of pipeline of drug candidates modulating distinct nervous system targets, including Kv7 ion channels, glutamate receptors, myostatin, and transient receptor potential channels.
Date Close
04/22/2024$38.33
04/23/2024$39.61
04/24/2024$38.72
04/25/2024$38.54
04/26/2024$38.97

BHVN Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.